Skip to main content
. 2022 Dec 1;26:373. doi: 10.1186/s13054-022-04192-w

Fig. 1.

Fig. 1

Participant and analysis population flow chart. CE Clinically evaluable, C/T Ceftolozane/tazobactam, ITT Intention-to-treat, ME Microbiologically evaluable, mITT Microbiologic intention-to-treat, N Number of participants in specific analysis population